Published Jul 20, 2020
Silverdragon102, BSN
1 Article; 39,477 Posts
The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.
The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.
The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.
The initial findings suggest the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by 79%.
Coronavirus: Protein treatment trial 'a breakthrough'
Interesting read
SabioUno
16 Posts
sounds promising. thanks!
toomuchbaloney
14,935 Posts
We certainly need this since a percentage of Americans seem intent upon causing as many infections as possible through ignorant and selfish behavior.
herring_RN, ASN, BSN
3,651 Posts
Scientists and physicians have discovered treatments that help more people survive COVID-19.
I continue praying for a vaccine and/or long term treatment like they did for HIV.
sevensonnets
975 Posts
This does sound like it has great potential.
Kitiger, RN
1,834 Posts
And here is yet one more reason for me to social distance, mask up, etc., now. If I have to get COVID, I want to get it later, when we know more and have better treatments.
This certainly looks hopeful.
I've considering raising llamas for the antibodies but there's no room for them on my front porch. Scared they might eat my veggies. I think I'll wait for this one instead!
Kooky Korky, BSN, RN
5,216 Posts
This is fabulous news! Let's hope there is more good news very soon.